Journal article · 2008

CCR5 as Target for HIV-1 Gene Therapy

Reza Nazari, Sadhna Joshi

Current Gene Therapy, 8(4), 264–272 · Published 1 August 2008 · DOI 10.2174/156652308785160674

View at the publisherCite this paper

In brief

“CCR5 as Target for HIV-1 Gene Therapy” is a 2008 journal article by Reza Nazari and Sadhna Joshi, published in Current Gene Therapy. OpenAlex counts 29 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
29
Most cited in
2012 (4)
Field-weighted impact
1.08
References
115
Authors
2

Abstract

Acquired immune deficiency syndrome (AIDS) is caused by a lentivirus, human immunodeficiency virus type-1 (HIV-1). Viral entry is mediated by specific interaction of the viral envelope (Env) glycoprotein with a cell surface molecule CD4 which serves as the primary receptor and a chemokine (C-C or C-X-C motif) receptor CCR5 or CXCR4 which serves as a… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Nazari, R., & Joshi, S. (2008). CCR5 as Target for HIV-1 Gene Therapy. Current Gene Therapy, 8(4), 264–272. https://doi.org/10.2174/156652308785160674

MLA 9

Nazari, Reza, and Sadhna Joshi. “CCR5 as Target for HIV-1 Gene Therapy.” Current Gene Therapy, vol. 8, no. 4, 2008, pp. 264–272. https://doi.org/10.2174/156652308785160674.

Chicago

Nazari, Reza and Sadhna Joshi. 2008. “CCR5 as Target for HIV-1 Gene Therapy.” Current Gene Therapy 8 (4): 264–272. https://doi.org/10.2174/156652308785160674.

Harvard

Nazari, R. and Joshi, S. (2008) ‘CCR5 as Target for HIV-1 Gene Therapy’, Current Gene Therapy, 8(4), pp. 264–272. doi:10.2174/156652308785160674.

IEEE

R. Nazari and S. Joshi, “CCR5 as Target for HIV-1 Gene Therapy,” Current Gene Therapy, vol. 8, no. 4, pp. 264–272, 2008, doi: 10.2174/156652308785160674.

BibTeX

@article{nazari2008target,
  title     = {{CCR5 as Target for HIV-1 Gene Therapy}},
  author    = {Nazari, Reza and Joshi, Sadhna},
  journal   = {Current Gene Therapy},
  year      = {2008},
  volume    = {8},
  number    = {4},
  pages     = {264--272},
  doi       = {10.2174/156652308785160674},
  url       = {https://doi.org/10.2174/156652308785160674}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201244
201311
201422
201533
201611
201711
201811
201922
202311
202511

Its field-weighted citation impact is 1.08: it has been cited 1.08 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • CCR5
  • HIV-1
  • gene therapy
  • chemokine coreceptors
  • HIV-1 entry
  • CD4 receptor
  • CXCR4
  • intrabodies

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Nazari, R., & Joshi, S. (2008). CCR5 as Target for HIV-1 Gene Therapy. Current Gene Therapy, 8(4), 264–272. https://doi.org/10.2174/156652308785160674

How many times has this paper been cited?

29 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Reza Nazari, Sadhna Joshi.

What is the DOI of this paper?

10.2174/156652308785160674, permanently at https://doi.org/10.2174/156652308785160674. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.